| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5928098 | American Heart Journal | 2016 | 21 Pages |
Abstract
Initiation of β-blocker therapy after AMI was not associated with an increase in depressive symptoms. Restricting β-blocker use because of concerns about depression appears unwarranted and may lead to undertreatment of AMI patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anil M. MD, John A. MD, MPH, Donna M. PHD, Kensey L. MS, Paul S. MD, MSc,